Evidence map›Paper›PMID 42029829›Full record

ArticleMolecular biomedicine2026

Development and characterization of 3D spinal cord organoids to advance the study of amyotrophic lateral sclerosis.

Matteo Bordoni, Eveljn Scarian, Letizia Messa, Maria Garofalo, Emanuela Jacchetti, Manuela Teresa Raimondi, Luca Diamanti, Stella Gagliardi, Stephana Carelli, Cristina Cereda and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matteo BordoniCellular Models and Neuroepigenetics Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Eveljn ScarianCellular Models and Neuroepigenetics Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Letizia MessaDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, 20133, Milan, Italy.
Maria GarofaloMolecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Emanuela JacchettiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico Di Milano, 20133, Milan, Italy.
Manuela Teresa RaimondiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico Di Milano, 20133, Milan, Italy.
Luca DiamantiNeuroncology Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Stella GagliardiMolecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy.
Stephana Carelli *Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, 20154, Milan, Italy.
Cristina Cereda *Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, 20154, Milan, Italy.
Orietta Pansarasa *Cellular Models and Neuroepigenetics Unit, IRCCS Mondino Foundation, 27100, Pavia, Italy. orietta.pansarasa@mondino.it.

Funding

BraYn Association Starting GrantMinistero della Salute RC2025-2027
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42029829
PMCPMC13109475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.